Log in to save to my catalogue

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer...

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_836f8e12f9da4729871114891e1bf178

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab

About this item

Full title

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab

Publisher

England: BioMed Central Ltd

Journal title

BMC neurology, 2012-09, Vol.12 (1), p.95-95, Article 95

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The balance between T helper cells Th2- and Th1-related cytokines plays a key role in multiple sclerosis (MS). A shift from a Th1 towards a Th2 cytokine profile could have a beneficial effect on the clinical course of the disease. The objective of this study was to assess Th2/Th1 cytokine profile in relapsing-remitting MS (RRMS) patients receiving...

Alternative Titles

Full title

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_836f8e12f9da4729871114891e1bf178

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_836f8e12f9da4729871114891e1bf178

Other Identifiers

ISSN

1471-2377

E-ISSN

1471-2377

DOI

10.1186/1471-2377-12-95

How to access this item